Salesforce: $60 Billion Target Tests Investors' Memories

Salesforce stock has a new bold $60 billion FY30 target, but growth doubts and high valuation persist. See why investors ...

The Real Reasons Behind the Closure of 'Try for Real': Insights from 游學修

In the interview, 游學修 highlighted a crucial tension in the creative process: the balance between personal artistic expression and audience satisfaction. He revealed that many artists within the team ...

Popular Cars You Should Avoid Buying, According To Consumer Reports

Popularity can be a good indication of quality, but there are lots of reason why it can be a bit of a red herring, too. Just ...
Applied Clinical Trials Online

After the Trial is too Late: The Case for More Active Use of Patient-Reported Outcomes in Oncology Studies

Patient-reported outcomes (PROs) are widely used in oncology clinical trials to capture patients’ own perspectives on ...

New Report Uncovers What Sponsors Really Think About Preclinical Services and CROs

Life Science Strategy Group (LSSG), a leading provider of strategic market insights for the life sciences industry, has released its highly anticipated Preclinical Services Landscape and CRO ...